Breaking News, Collaborations & Alliances

Gerresheimer/Corning Form Joint Venture to Meet Growing Demand for Velocity Vials

The alliance addresses the need for a high-quality, cost-effective injectable drug filling process.

Gerresheimer AG, the leading global provider of healthcare, beauty, and drug delivery systems for pharma, biotech, and cosmetics, announced a joint venture with Corning Incorporated, an innovator in materials science and manufacturing, to increase global access to the Velocity Vial technology platform. The alliance addresses the need for a high-quality, and cost-effective injectable drug filling process. “As the leading solution provider for the pharma and biotech industry, Gerreshei...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters